Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Leukemia
|
April 18, 2006
Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
G J Roboz, F J Giles, A F List, et al.
Bone Marrow Transplantation
|
February 16, 2000
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group
A F List, R Maziarz, P Stiff, et al.
Blood
|
March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
A F List, C S Spier, T M Grogan, et al.
Ecancermedicalscience
|
January 26, 2012
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update
L R Silverman, P Fenaux, G J Mufti, et al.
Blood
|
November 24, 2001
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
A F List, K J Kopecky, C L Willman, et al.
Leukemia
|
July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia
J E Lancet, F Ravandi, R M Ricklis, et al.
Ecancermedicalscience
|
January 26, 2012
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update
P Fenaux, G J Mufti, E Hellström-Lindberg, et al.
Leukemia
|
March 14, 2009
Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome
J X Zou, D E Rollison, D Boulware, et al.
Leukemia
|
October 18, 2012
Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency
L Yang, A Mailloux, D E Rollison, et al.
Leukemia
|
August 26, 2016
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide
E Negoro, T Radivoyevitch, C Polprasert, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Leukemia
|
April 18, 2006
Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
G J Roboz, F J Giles, A F List, et al.
Bone Marrow Transplantation
|
February 16, 2000
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group
A F List, R Maziarz, P Stiff, et al.
Blood
|
March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
A F List, C S Spier, T M Grogan, et al.
Ecancermedicalscience
|
January 26, 2012
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update
L R Silverman, P Fenaux, G J Mufti, et al.
Blood
|
November 24, 2001
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
A F List, K J Kopecky, C L Willman, et al.
Leukemia
|
July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia
J E Lancet, F Ravandi, R M Ricklis, et al.
Ecancermedicalscience
|
January 26, 2012
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update
P Fenaux, G J Mufti, E Hellström-Lindberg, et al.
Leukemia
|
March 14, 2009
Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome
J X Zou, D E Rollison, D Boulware, et al.
Leukemia
|
October 18, 2012
Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency
L Yang, A Mailloux, D E Rollison, et al.
Leukemia
|
August 26, 2016
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide
E Negoro, T Radivoyevitch, C Polprasert, et al.
Page
of 10